OAKLAND PARK, Fla., Aug. 12, 2019 /PRNewswire/ -- Darin Bush, DO with Mobility Spine and Sports is implementing a non-invasive and drug-free solution for Erectile Dysfunction (ED). This cutting-edge procedure boasts a 75% success rate amongst patients. The treatment is called

HOUSTON, Aug. 12, 2019 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), today announced that the Company has initiated patient recruitme

TAIZHOU, China, Aug. 12, 2019 /PRNewswire/ -- China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) ("China SXT" or the "Company"), a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces ("TCMPs"), announced today that it has been issued a new Certificat

OAK BROOK, Ill., Aug. 12, 2019 /PRNewswire/ -- Summer break is in full swing, but our oral health requires studious attention all year round. According to the Children's Oral Health Survey, nearly 1 in 2 parents in America is challenged with getting their kids to practice proper oral care. Moms and dads share that two of the most daunting tasks as a caregiver

BOSTON, Aug. 12, 2019 /PRNewswire/ -- Linking employees and their family members with qualified  mental health professionals is a critical but often overlooked tool in preventing opioid abuse, according to experts from

VAUGHAN, ON, Aug. 12, 2019 /PRNewswire/ - CannTrust Holdings Inc. ("CannTrust" or the "Company", TSX: TRST, NYSE: CTST) provided an interim update concerning certain recent developments affecting the Company.

ROCKVILLE, Md., Aug. 12, 2019 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing therapeutics and pharmaceutical products in China, U.S., and throughout the world, announces the product launch of EVOMELA® (melphalan for injection) in

SAN FRANCISCO, Aug. 12, 2019 /PRNewswire/ -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage biotechnology company developing transformational treatments for patients with non-alcoholic steatohepatitis (NASH) and other serious metabolic disorders, today provided a business update and reported second quarter 2019 financial results for the period ending

WALTHAM, Mass., Aug. 12, 2019 /PRNewswire/ -- Oncologie, Inc., a clinical-stage biopharmaceutical company developing innovative oncology treatments targeting the tumor microenvironment, today announced that it has entered into a clinical collaboration agreement with Merck (known as MSD outside the US and Canada) to evaluate the combi

BILLERICA, Mass., Aug. 12, 2019 /PRNewswire/ -- Bruker Corporation (Nasdaq: BRKR) today announced that its Board of Directors has approved payment of a quarterly cash dividend in the amount of $0.04 per share on the Company's common stock. The dividend will be paid on September 20, 2019 to stockholders of record as of